Close Menu

Investigators at Ludwig-Maximilians-University show in an SNP analysis on a population of 2,196 people — including 913 Crohn's disease patients, 318 ulcerative colitis patients, and 965 healthy, unrelated controls — that "rs6887695 modulates the susceptibility and the phenotype of IBD [inflammatory bowel disease]." Writing in PLoS One this week, the authors add that the SNP's effect on inflammatory bowel disease susceptibility "is less pronounced than that of IL23R gene variant

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Two COVID-19 vaccine developers have released their trial protocols to build public trust, the New York Times reports.

A new analysis finds the rapid COVID-19 test from DnaNudge to be highly accurate, Reuters reports.

In Science this week: global citizens' assembly on genome-editing technologies proposed, epigenetic markers predict metformin response, and more.

According to the Verge, many US states are not including positive results from rapid COVID-19 testing in their case numbers.